FV04 Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice

Wagner, N. and Lenders, M. M. and Kühl, K. and Reinhardt, L. and Fuchss, M. and Ring, N. and Richtig, G. and Ebel, C. and Andre, F. and Stäger, R. and Zellweger, C. and Stürmer, S. H. and Lang, R. and Paar, M. and Gussek, P. and Kimeswenger, S. and Oellinger, A. and Amaral, T. and Forschner, A. and Leiter-Stöppke, U. and Weide, B. and Gassenmaier, M. and Schraag, A. and Klumpp, B. and Hoetzenecker, W. and Ziemer, M. and Berking, C. and Mangana, J. and Nguyen, V. A. and Terheyden, P. and Richtig, E. and Loquai, C. and Diem, S. and Cozzio, A. and Röcken, M. and Garbe, C. and Gebhardt, C. and Meier, F. and Eigentler, T. and Flatz, L. (2022) FV04 Site-specific tumor response and survival in patients with metastatic melanoma receiving immune checkpoint inhibition or targeted therapy: implications for treatment choice. In: 32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Orthopädie
Depositing User:	Petra Gürster
Date Deposited:	12 Oct 2023 07:02
Last Modified:	12 Oct 2023 07:02
URI:	https://pred.uni-regensburg.de/id/eprint/58800

Actions (login required)

View Item